- Home
- HGLB vs ME Comparison
HGLB vs ME Comparison
Compare HGLB & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGLB
- ME
- Stock Information
- Founded
- HGLB 1998
- ME 2006
- Country
- HGLB United States
- ME United States
- Employees
- HGLB N/A
- ME N/A
- Industry
- HGLB Trusts Except Educational Religious and Charitable
- ME Precision Instruments
- Sector
- HGLB Finance
- ME Health Care
- Exchange
- HGLB Nasdaq
- ME Nasdaq
- Market Cap
- HGLB 176.4M
- ME 98.7M
- IPO Year
- HGLB N/A
- ME N/A
- Fundamental
- Price
- HGLB $7.55
- ME $3.39
- Analyst Decision
- HGLB
- ME Hold
- Analyst Count
- HGLB 0
- ME 1
- Target Price
- HGLB N/A
- ME $9.40
- AVG Volume (30 Days)
- HGLB 91.8K
- ME 219.4K
- Earning Date
- HGLB 01-01-0001
- ME 02-05-2025
- Dividend Yield
- HGLB 13.16%
- ME N/A
- EPS Growth
- HGLB N/A
- ME N/A
- EPS
- HGLB N/A
- ME N/A
- Revenue
- HGLB N/A
- ME $193,260,000.00
- Revenue This Year
- HGLB N/A
- ME $21.93
- Revenue Next Year
- HGLB N/A
- ME $17.31
- P/E Ratio
- HGLB N/A
- ME N/A
- Revenue Growth
- HGLB N/A
- ME N/A
- 52 Week Low
- HGLB $6.42
- ME $2.66
- 52 Week High
- HGLB $9.45
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- HGLB 58.59
- ME 44.56
- Support Level
- HGLB $7.35
- ME $3.15
- Resistance Level
- HGLB $7.44
- ME $4.18
- Average True Range (ATR)
- HGLB 0.15
- ME 0.26
- MACD
- HGLB 0.06
- ME 0.05
- Stochastic Oscillator
- HGLB 94.12
- ME 29.46
About HGLB Highland Global Allocation Fund
Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.